<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">36247234</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2397-9070</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>JGH open : an open access journal of gastroenterology and hepatology</Title><ISOAbbreviation>JGH Open</ISOAbbreviation></Journal><ArticleTitle>Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.</ArticleTitle><Pagination><StartPage>667</StartPage><EndPage>676</EndPage><MedlinePgn>667-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jgh3.12811</ELocationID><Abstract><AbstractText>Post-COVID conditions, also known as post-acute sequelae of SARS-CoV-2 (PASC), refer to the persistence of symptoms in COVID-19 long-haulers. Various manifestations of post-COVID conditions are general symptoms and/or manifestations of damage in multiple organs. Besides, SARS-CoV-2 can involve the gastrointestinal tract, resulting in sequelae such as diarrhea, abdominal pain, nausea, anorexia, vomiting, constipation, abdominal distension, acid reflux, and/or gastrointestinal bleeding. Previous investigations point to SARS-CoV-2 entry into enterocytes enhances by the angiotensin-converting enzyme 2 (ACE2) receptors. Interestingly, ACE2 receptors are abundantly expressed in the gut, implying infection with SARS-CoV-2 might occur through this route as well as in the respiratory tract. According to mounting evidence, SARS-CoV-2 RNA has been identified in fecal specimens of patients with COVID-19 during and beyond the acute phase. In addition, studies have shown gut microbiome composition is altered in patients with PASC, hence, another putative mechanism linked to gastrointestinal symptoms is gut dysbiosis. The presence of the gut-lung axis in COVID-19 might have major implications for disease pathogenesis and treatment. This review discussed the prevalence of gastrointestinal symptoms and pathophysiology underlying possible infection of the gut in patients with PASC. Also, SARS-COV-2 induced NLRP3 inflammasome-dependent inflammatory pathways are briefly addressed.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Norouzi Masir</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee School of Medicine, Shahrekord University of Medical Sciences Shahrekord Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirvaliloo</LastName><ForeName>Milad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5122-1274</Identifier><AffiliationInfo><Affiliation>Infectious &amp; Tropical Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>JGH Open</MedlineTA><NlmUniqueID>101730833</NlmUniqueID><ISSNLinking>2397-9070</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">NLRP3</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">gastrointestinal sequelae</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">gut&#x2010;lung axis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post&#x2010;COVID conditions</Keyword><Keyword MajorTopicYN="N">post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36247234</ArticleId><ArticleId IdType="pmc">PMC9538198</ArticleId><ArticleId IdType="doi">10.1002/jgh3.12811</ArticleId><ArticleId IdType="pii">JGH312811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beltr&#xe1;n&#x2010;Camacho L, Eslava&#x2010;Alc&#xf3;n S, Rojas&#x2010;Torres M et al. The serum of COVID&#x2010;19 asymptomatic patients up&#x2010;regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex&#x2010;vivo. Mol. Med. 2022; 28: 40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994070</ArticleId><ArticleId IdType="pubmed">35397534</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397: 220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post&#x2010;acute sequelae of COVID&#x2010;19. Front. Immunol. 2021; 12: 686029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Helbok R, Crean M et al. The European Academy of Neurology COVID&#x2010;19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID&#x2010;19. Eur. J. Neurol. 2021; 28: 3303&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753513</ArticleId><ArticleId IdType="pubmed">33220127</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: a cross&#x2010;sectional evaluation. J. Med. Virol. 2021; 93: 1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS&#x2010;CoV&#x2010;2 infection: illness beyond acute infection and public health implications. J Am Med Assoc. 2020; 324: 2251&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE Overview|COVID&#x2010;19 rapid guideline: managing the long&#x2010;term effects of COVID&#x2010;19|Guidance|NICE . Cited 2 May 2022.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . Post&#x2010;COVID Conditions|CDC. Save Lives, Prot People . Cited 2 May 2022.</Citation></Reference><Reference><Citation>Romero&#x2010;Duarte &#xc1;, Rivera&#x2010;Izquierdo M, Guerrero&#x2010;Fern&#xe1;ndez de Alba I et al. Sequelae, persistent symptomatology and outcomes after COVID&#x2010;19 hospitalization: the ANCOHVID multicentre 6&#x2010;month follow&#x2010;up study. BMC Med. 2021; 19: 129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B, Erinoso O, Wright KO et al. &#x2018;Long COVID&#x2019;: persistent COVID&#x2010;19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect. Dis. 2021; 21: 304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE et al. Respiratory and psychophysical sequelae among patients with covid&#x2010;19 four months after hospital discharge. JAMA Netw. Open. 2021; 4: e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL et al. Inflammation&#x2010;type dysbiosis of the oral microbiome associates with the duration of COVID&#x2010;19 symptoms and long COVID. JCI Insight. 2021; 6: e152346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. J. Am. Med. Assoc. 2020; 324: 603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Carf&#xec; A, Benvenuto F et al. Predictive factors for a new positive nasopharyngeal swab among patients recovered from COVID&#x2010;19. Am. J. Prev. Med. 2021; 60: 13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500946</ArticleId><ArticleId IdType="pubmed">33041095</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N et al. Three&#x2010;month follow&#x2010;up study of survivors of coronavirus disease 2019 after discharge. J. Korean Med. Sci. 2020; 35: e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Bai F, Castoldi R et al. Anxiety and depression symptoms after virological clearance of COVID&#x2010;19: a cross&#x2010;sectional study in Milan, Italy. J Med Virol. 2021; 93: 1175&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno&#x2010;P&#xe9;rez O, Merino E, Leon&#x2010;Ramirez JM et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. 2021; 82: 378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Xie Y, Bowe B. High&#x2010;dimensional characterization of post&#x2010;acute sequelae of COVID&#x2010;19. Nature. 2021; 594: 259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin. Infect. Dis. 2021; 73: E4058&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID&#x2010;19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. Morb. Mortal. Wkly Rep. 2020; 69: 993&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J et al. Multiorgan impairment in low&#x2010;risk individuals with post&#x2010;COVID&#x2010;19 syndrome: a prospective, community&#x2010;based study. BMJ Open. 2021; 11: e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyung PS, Lee CW, Park DI et al. Detection of SARS&#x2010;CoV&#x2010;2 in fecal samples from patients with asymptomatic and mild COVID&#x2010;19 in Korea. Clin. Gastroenterol. Hepatol. 2021; 19: 1387&#x2013;1394.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao ZY, Min SY, Bin SW et al. Follow&#x2010;up study of the pulmonary function and related physiological characteristics of COVID&#x2010;19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM et al. Persistent symptoms 3 months after a SARS&#x2010;CoV&#x2010;2 infection: the post&#x2010;COVID&#x2010;19 syndrome? ERJ Open Res. 2020; 6: 00542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C et al. Follow up of patients with severe coronavirus disease 2019 (COVID&#x2010;19): pulmonary and extrapulmonary disease sequelae. Respir. Med. 2020; 174: 106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro&#x2010;P&#xe9;rez M, Mart&#xed;n&#x2010;Garc&#xed;a A et al. Afecci&#xf3;n peric&#xe1;rdica y mioc&#xe1;rdica tras infecci&#xf3;n por SARS&#x2010;CoV&#x2010;2: estudio descriptivo transversal en trabajadores sanitarios. Rev Espa&#xf1;ola Cardiol. 2022; 75: 735&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755423</ArticleId><ArticleId IdType="pubmed">35039707</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n&#x2010;Tejada CE, Herrera&#x2010;Garc&#xed;a CF, Godina&#x2010;Gonz&#xe1;lez S et al. Persistence of covid&#x2010;19 symptoms after recovery in Mexican population. Int. J. Environ. Res. Public Health. 2020; 17: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky&#x2010;Di Bari D et al. Persistence of symptoms and quality of life at 35&#x2009;days after hospitalization for COVID&#x2010;19 infection. PLoS One. 2020; 15: e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022; 162: 648&#x2013;650.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Li Y, Li J et al. Gastrointestinal sequelae 90&#x2009;days after discharge for COVID&#x2010;19. Lancet Gastroenterol. Hepatol. 2021; 6: 344&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co&#x2010;occurrence, and evolution of long&#x2010;COVID features: a 6&#x2010;month retrospective cohort study of 273,618 survivors of COVID&#x2010;19. PLoS Med. 2021; 18: e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu H, Jiang H et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM An Int J Med. 2020; 113: 657&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho&#x2010;Schneider C, Laurent E, Lemaignen A et al. Follow&#x2010;up of adults with noncritical COVID&#x2010;19 two months after symptom onset. Clin. Microbiol. Infect. 2021; 27: 258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C, Viana SD, Reis F. Gut microbiota dysbiosis&#x2013;immune hyperresponse&#x2013;inflammation triad in coronavirus disease 2019 (Covid&#x2010;19): impact of pharmacological and nutraceutical approaches. Microorganisms. 2020; 8: 1&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7601735</ArticleId><ArticleId IdType="pubmed">33019592</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignesh R, Swathirajan CR, Tun ZH, Rameshkumar MR, Solomon SS, Balakrishnan P. Could perturbation of gut microbiota possibly exacerbate the severity of COVID&#x2010;19 via cytokine storm? Front. Immunol. 2021; 11: 607734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868418</ArticleId><ArticleId IdType="pubmed">33569053</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Ye G, Shi K et al. Structural basis of receptor recognition by SARS&#x2010;CoV&#x2010;2. Nature. 2020; 581: 221&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Zhong L, Deng J et al. High expression of ACE2 receptor of 2019&#x2010;nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020; 12: 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS&#x2010;CoV&#x2010;2. Gastroenterology. 2020; 158: 1831&#x2013;1833.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Liang TJ. Is SARS&#x2010;CoV&#x2010;2 also an enteric pathogen with potential fecal&#x2013;oral transmission? A COVID&#x2010;19 virological and clinical review. Gastroenterology. 2020; 159: 53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184994</ArticleId><ArticleId IdType="pubmed">32353371</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlot T, Penninger JM. ACE2 &#x2010; From the renin&#x2010;angiotensin system to gut microbiota and malnutrition. Microbes Infect. 2013; 15: 866&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110844</ArticleId><ArticleId IdType="pubmed">23962453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T, Perlot T, Rehman A et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012; 487: 477&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS&#x2010;CoV&#x2010;2. Cardiovasc. Res. 2020; 116: 1097&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Chakraborty S, Saha P et al. Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS&#x2010;CoV&#x2010;2 infectivity. Hypertension. 2020; 76: 1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379164</ArticleId><ArticleId IdType="pubmed">32426999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkman R, Jebbink MF, Deijs M et al. Replication&#x2010;dependent downregulation of cellular angiotensin&#x2010;converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. 2012; 93: 1924&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22718567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY et al. Gastrointestinal manifestations of SARS&#x2010;CoV&#x2010;2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta&#x2010;analysis. Gastroenterology. 2020; 159: 81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Effenberger M, Grabherr F, Mayr L et al. Faecal calprotectin indicates intestinal inflammation in COVID&#x2010;19. Gut. 2020; 69: 1543&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211078</ArticleId><ArticleId IdType="pubmed">32312790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, Van Der VJ et al. SARS&#x2010;CoV&#x2010;2 productively infects human gut enterocytes. Science. 2020; 369: 50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed Mim M, Naznin Rakhi N, Saha O, Rahaman MM. Recommendation of fecal specimen for routine molecular detection of SARS&#x2010;CoV&#x2010;2 and for COVID&#x2010;19 discharge criteria. Pathog Glob Health. 2020; 114: 168&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448890</ArticleId><ArticleId IdType="pubmed">32407189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L et al. Prolonged presence of SARS&#x2010;CoV&#x2010;2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020; 5: 434&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F et al. Depicting SARS&#x2010;CoV&#x2010;2 faecal viral activity in association with gut microbiota composition in patients with COVID&#x2010;19. Gut. 2021; 70: 276&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC et al. Evolution of antibody immunity to SARS&#x2010;CoV&#x2010;2. Nature. 2021; 591: 639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Villapol S. Gastrointestinal symptoms associated with COVID&#x2010;19: impact on the gut microbiome. Transl. Res. 2020; 226: 57&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438210</ArticleId><ArticleId IdType="pubmed">32827705</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GCY et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID&#x2010;19. Gut. 2021; 70: 698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H, Pigneur B, Watterlot L et al. Faecalibacterium prausnitzii is an anti&#x2010;inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 16731&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575488</ArticleId><ArticleId IdType="pubmed">18936492</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada Venegas D, De la Fuente MK, Landskron G et al. Short chain fatty acids (SCFAs)&#x2010;mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 2019; 10: 277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421268</ArticleId><ArticleId IdType="pubmed">30915065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira&#x2010;Halder CV, de Sousa Faria AV, Andrade SS. Action and function of Faecalibacterium prausnitzii in health and disease. Best Pract. Res. Clin. Gastroenterol. 2017; 31: 643&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29566907</ArticleId></ArticleIdList></Reference><Reference><Citation>Breyner NM, Michon C, de Sousa CS et al. Microbial anti&#x2010;inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS&#x2010;induced colitis model in mice through inhibition of NF&#x2010;&#x3ba;B pathway. Front. Microbiol. 2017; 8: 114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5285381</ArticleId><ArticleId IdType="pubmed">28203226</ArticleId></ArticleIdList></Reference><Reference><Citation>Alameddine J, Godefroy E, Papargyris L et al. Faecalibacterium prausnitzii skews human DC to prime IL10&#x2010;producing T cells through TLR2/6/JNK signaling and IL&#x2010;10, IL&#x2010;27, CD39, and IDO&#x2010;1 induction. Front. Immunol. 2019; 10: 143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373781</ArticleId><ArticleId IdType="pubmed">30787928</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A, Cattane N, Galluzzi S et al. Association of brain amyloidosis with pro&#x2010;inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging. 2017; 49: 60&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F et al. Alterations in fecal fungal microbiome of patients with COVID&#x2010;19 during time of hospitalization until discharge. Gastroenterology. 2020; 159: 1302&#x2013;1310.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q et al. Gut microbiota dynamics in a prospective cohort of patients with post&#x2010;acute COVID&#x2010;19 syndrome. Gut. 2022; 71: 544&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri MH, Brummer RJM, Rastall RA et al. The role of the microbiome for human health: from basic science to clinical applications. Eur. J. Nutr. 2018; 57: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962619</ArticleId><ArticleId IdType="pubmed">29748817</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompette A, Gollwitzer ES, Pattaroni C et al. Dietary fiber confers protection against flu by shaping Ly6c&#x2212;patrolling monocyte hematopoiesis and CD8+ T cell metabolism. Immunity. 2018; 48: 992&#x2013;1005.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29768180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben&#xed;tez&#x2010;P&#xe1;ez A, G&#xf3;mez del Pugar EM, L&#xf3;pez&#x2010;Almela I, Moya&#x2010;P&#xe9;rez &#xc1;, Codo&#xf1;er&#x2010;Franch P, Sanz Y. Depletion of blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. mSystems. 2020; 5: e00857&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093825</ArticleId><ArticleId IdType="pubmed">32209719</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis&#x2010;Richardson AG, Ardissone AN, Dias R et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front. Microbiol. 2014; 5: 678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261809</ArticleId><ArticleId IdType="pubmed">25540641</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin. Immunopathol. 2015; 37: 47&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281375</ArticleId><ArticleId IdType="pubmed">25420450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gu S, Chen Y et al. Six&#x2010;month follow&#x2010;up of gut microbiota richness in patients with COVID&#x2010;19. Gut. 2022; 71: 222&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat. Immunol. 2019; 20: 1279&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">31501577</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CR. Microbiota modulation of the gut&#x2010;lung axis in COVID&#x2010;19. Front. Immunol. 2021; 12: 635471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauguet S, D'Ortona S, Ahnger&#x2010;Pier K et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 2015; 83: 4003&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4567647</ArticleId><ArticleId IdType="pubmed">26216419</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes KH, Fachi JL, de Paula R et al. Microbiota&#x2010;derived acetate protects against respiratory syncytial virus infection through a GPR43&#x2010;type 1 interferon response. Nat. Commun. 2019; 10: 3273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Hu J, Feng JW et al. Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection. Genome Biol. 2020; 21: 99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187530</ArticleId><ArticleId IdType="pubmed">32345342</ArticleId></ArticleIdList></Reference><Reference><Citation>Steed AL, Christophi GP, Kaiko GE et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science. 2017; 357: 498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753406</ArticleId><ArticleId IdType="pubmed">28774928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Pang IK, Kumamoto Y et al. Microbiota regulates immune defense against respiratory tract influenza a virus infection. Proc. Natl. Acad. Sci. U. S. A. 2011; 108: 5354&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069176</ArticleId><ArticleId IdType="pubmed">21402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiotamediated Th17 cell&#x2010;dependent inflammation. J. Exp. Med. 2014; 211: 2397&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4235643</ArticleId><ArticleId IdType="pubmed">25366965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze MA, Tsuruta M, Yang SWJ et al. Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One. 2014; 9: e111228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205020</ArticleId><ArticleId IdType="pubmed">25333938</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang AT, Marsland BJ. Microbes, metabolites, and the gut&#x2013;lung axis. Mucosal Immunol. 2019; 12: 843&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">30976087</ArticleId></ArticleIdList></Reference><Reference><Citation>Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links between inflammatory bowel disease and chronic obstructive pulmonary disease. Front. Immunol. 2020; 11: 2144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7517908</ArticleId><ArticleId IdType="pubmed">33042125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID&#x2010;19. Am. J. Physiol. Gastrointest. Liver Physiol. 2020; 319: G245&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414235</ArticleId><ArticleId IdType="pubmed">32639848</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaibani P, Viciani E, Bartoletti M et al. The lower respiratory tract microbiome of critically ill patients with COVID&#x2010;19. Sci. Rep. 2021; 11: 10103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115177</ArticleId><ArticleId IdType="pubmed">33980943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 2010; 10: 210&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">20168318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015; 70: 1199&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">26493990</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL&#x2010;1&#x3b2;&#x2010;processing inflammasome with increased activity in Muckle&#x2010;Wells autoinflammatory disorder. Immunity. 2004; 20: 319&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15030775</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi L, Eigenbrod T, Mu&#xf1;oz&#x2010;Planillo R, Nu&#xf1;ez G. The inflammasome: a caspase&#x2010;1&#x2010;activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009; 10: 241&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820724</ArticleId><ArticleId IdType="pubmed">19221555</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell GR, To RK , Hanna J, Spector SA. SARS&#x2010;CoV&#x2010;2, SARS&#x2010;CoV&#x2010;1, and HIV&#x2010;1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non&#x2010;classical pathway. iScience. 2021; 24: 102295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939994</ArticleId><ArticleId IdType="pubmed">33718825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019; 20: 3328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg DF, te Velde AA. Severe COVID&#x2010;19: NLRP3 inflammasome dysregulated. Front. Immunol. 2020; 11: 1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332883</ArticleId><ArticleId IdType="pubmed">32670297</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013; 13: 397&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807999</ArticleId><ArticleId IdType="pubmed">23702978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Xie X, Feng XL et al. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID&#x2010;19 like pathology in mice. EBioMedicine. 2022; 75: 103803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719059</ArticleId><ArticleId IdType="pubmed">34979342</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul O, Tao JQ, West E et al. Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID&#x2010;19): possible role for the NLRP3 inflammasome. Respir. Res. 2022; 23: 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8830114</ArticleId><ArticleId IdType="pubmed">35144622</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Akinyemi IA, Chitre SA et al. SARS&#x2010;CoV&#x2010;2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology. 2022; 568: 13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762580</ArticleId><ArticleId IdType="pubmed">35066302</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P, Shen M, Yu Z et al. SARS&#x2010;CoV&#x2010;2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021; 12: 4664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalcinkaya M, Liu W, Islam MN et al. Modulation of the NLRP3 inflammasome by Sars&#x2010;CoV&#x2010;2 envelope protein. Sci. Rep. 2021; 11: 24432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709866</ArticleId><ArticleId IdType="pubmed">34952919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Liu Y, Huang Z et al. SARS&#x2010;CoV&#x2010;2 non&#x2010;structural protein 6 triggers NLRP3&#x2010;dependent pyroptosis by targeting ATP6AP1. Cell Death Differ. 2022; 29: 1240&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177730</ArticleId><ArticleId IdType="pubmed">34997207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Zhao W. NLRP3 inflammasome&#x2014;a key player in antiviral responses. Front. Immunol. 2020; 11: 211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7040071</ArticleId><ArticleId IdType="pubmed">32133002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ero J, Sa&#xfc;ch J, Sanz F, Furlong LI. The DisGeNET cytoscape app: exploring and visualizing disease genomics data. Comput. Struct. Biotechnol. J. 2021; 19: 2960&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163863</ArticleId><ArticleId IdType="pubmed">34136095</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID&#x2010;19 in the New York City area. J Am Med Assoc. 2020; 323: 2052&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, de S&#xe1; KSG, Ishimoto AY et al. Inflammasomes are activated in response to SARS&#x2010;CoV&#x2010;2 infection and are associated with COVID&#x2010;19 severity in patients. J. Exp. Med. 2021; 218: e20201707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SU, Kamada N, Mu&#xf1;oz&#x2010;Planillo R et al. Distinct commensals induce interleukin&#x2010;1&#x3b2; via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity. 2015; 42: 744&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4408263</ArticleId><ArticleId IdType="pubmed">25862092</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y, Huang Y, Wang Y, Wang P, Song H, Wang F. Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy. PLoS One. 2019; 14: e0218384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581431</ArticleId><ArticleId IdType="pubmed">31211803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe PP, Gyongyosi B, Satishchandran A et al. Reduced gut microbiome protects from alcohol&#x2010;induced neuroinflammation and alters intestinal and brain inflammasome expression. J. Neuroinflammation. 2018; 15: 298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6203993</ArticleId><ArticleId IdType="pubmed">30368255</ArticleId></ArticleIdList></Reference><Reference><Citation>Man SM, Karki R, Sasai M et al. IRGB10 liberates bacterial ligands for sensing by the AIM2 and Caspase&#x2010;11&#x2010;NLRP3 inflammasomes. Cell. 2016; 167: 382&#x2013;396.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5074697</ArticleId><ArticleId IdType="pubmed">27693356</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>